Fospropofol Disodium
- Generic Name
- Fospropofol Disodium
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
作为静脉用全身麻醉剂，用于成人全身麻醉的诱导。
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Assess the Efficacy and Safety of Fospropofol Disodium
- First Posted Date
- 2011-01-06
- Last Posted Date
- 2011-01-06
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT01271569
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery
Phase 4
Terminated
- Conditions
- Interventions
- First Posted Date
- 2010-09-03
- Last Posted Date
- 2012-06-29
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 13
- Registration Number
- NCT01195103
- Locations
- 🇺🇸
Mayo Clinic, Phoenix, Arizona, United States
A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2008-11-07
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 270
- Registration Number
- NCT00209573
A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2009-12-04
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT00209534
A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures
Phase 3
Terminated
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-01-09
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 168
- Registration Number
- NCT00209560
A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy
Phase 3
Terminated
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT00209586
Study to Assess Safety and Efficacy of AQUAVAN® Injection for Sedation During Cardiac Catheterization
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2008-11-07
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 110
- Registration Number
- NCT00209547
A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Elective Colonoscopy
Phase 2
Terminated
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT00209599
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath